Growth Metrics

SBC Medical Group Holdings (SBC) Cost of Revenue (2023 - 2025)

SBC Medical Group Holdings filings provide 3 years of Cost of Revenue readings, the most recent being $10.6 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 0.85% to $10.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $46.3 million, a 6.16% decrease, with the full-year FY2025 number at $46.3 million, down 6.16% from a year prior.
  • Cost of Revenue hit $10.6 million in Q4 2025 for SBC Medical Group Holdings, down from $12.7 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $19.0 million in Q4 2023 to a low of $9.6 million in Q1 2025.
  • Median Cost of Revenue over the past 3 years was $13.0 million (2025), compared with a mean of $12.8 million.
  • Biggest five-year swings in Cost of Revenue: crashed 44.43% in 2024 and later increased 29.41% in 2025.
  • SBC Medical Group Holdings' Cost of Revenue stood at $19.0 million in 2023, then crashed by 44.43% to $10.5 million in 2024, then increased by 0.85% to $10.6 million in 2025.
  • The last three reported values for Cost of Revenue were $10.6 million (Q4 2025), $12.7 million (Q3 2025), and $13.3 million (Q2 2025) per Business Quant data.